Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | KZIAKazia Therapeutics LtdFY2025 · Jun |
|---|---|
| Revenue | $42.00K |
| Revenue, yoy | −98.2% |
| Net income | $20.70M |
| Net income, yoy | +22.7% |
| Net margin | -49,290.5% |
| Free cash flow | $11.45M |
| FCF margin | — |
| EPS, diluted | $0.04 |
Add another company.